The neuroprotective effect of agmatine after focal cerebral ischemia in diabetic rats

Journal of Neurosurgical Anesthesiology

Volumn 24, Issue 1, 2012, Pages 39-50

  Cui, Huisong ^a   Lee, Jae Hoon ^a   Kim, Ji Young ^a   Koo, Bon Nyeo ^a,b   Lee, Jong Eun ^b  

^a Anesthesia and Pain Research Institute   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Agmatine; Apoptosis; Diabetes; Infarct size; Nitric oxide synthase; Occlusion of middle cerebral artery

Indexed keywords

AGMATINE; CASPASE 3; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TREATMENT OUTCOME;

AGMATINE; ANIMALS; APOPTOSIS; BLOOD GLUCOSE; BLOTTING, WESTERN; BODY WEIGHT; BRAIN EDEMA; CEREBROVASCULAR CIRCULATION; DIABETES MELLITUS, EXPERIMENTAL; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC ATTACK, TRANSIENT; MALE; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY; ROTAROD PERFORMANCE TEST;

EID: 84857045924     PISSN: 08984921     EISSN: 15371921     Source Type: Journal    
DOI: 10.1097/ANA.0b013e318235af18     Document Type: Article

References (41)

1. Kissela BM, Khoury J, Kleindorfer D, et al. Epidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/ Northern Kentucky Stroke Study. Diabetes Care. 2005;28:355-359. (Pubitemid 40170939)
2. Hankey GJ, Jamrozik K, Broadhurst RJ, et al. Long-term risk of first recurrent stroke in the Perth Community Stroke Study. Stroke. 1998;29:2491-2500. (Pubitemid 28543996)
3. Megherbi SE, Milan C, Minier D, et al. Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project. Stroke. 2003;34:688-694. (Pubitemid 36307394)
4. Aragno M, Parola S, Brignardello E, et al. Dehydroepiandrosterone prevents oxidative injury induced by transient ischemia/reperfusion in the brain of diabetic rats. Diabetes. 2000;49:1924-1931.
5. Aragno M, Parola S, Tamagno E, et al. Oxidative derangement in rat synaptosomes induced by hyperglycaemia: restorative effect of dehydroepiandrosterone treatment. Biochem Pharmacol. 2000; 60:389-395. (Pubitemid 30336636)
6. Arvanitakis Z, Wilson RS, Bienias JL, et al. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol. 2004;61:661-666. (Pubitemid 38637681)
7. Nishikawa T, Edelstein D, Du XL, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000;404:787-790. (Pubitemid 30212409)
8. Bonnefont-Rousselot D. Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care. 2002;5:561-568. (Pubitemid 40684653)
9. Evans JL, Goldfine ID, Maddux BA, et al. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev. 2002;23:599-622. (Pubitemid 35191625)
10. Mastrocola R, Restivo F, Vercellinatto I, et al. Oxidative and nitrosative stress in brain mitochondria of diabetic rats. J Endocrinol. 2005;187:37-44. (Pubitemid 41556399)
11. Tabor CW, Tabor H. Polyamines. Annu Rev Biochem. 1984;53: 749-790. (Pubitemid 14059150)
12. Li G, Regunathan S, Barrow CJ, et al. Agmatine: an endogenous clonidine-displacing substance in the brain. Science. 1994;263: 966-969. (Pubitemid 24094560)
13. Lortie MJ, Novotny WF, Peterson OW, et al. Agmatine, bioactive metabolite of arginine. Production, degradation, and functional effects in the kidney of the rat. J Clin Invest. 1996;97:413-420.
14. Kim JH, Yenari MA, Giffard RG, et al. Agmatine reduces infarct area in a mouse model of transient focal cerebral ischemia and protects cultured neurons from ischemia-like injury. Exp Neurol. 2004;189:122-130. (Pubitemid 39024461)
15. Olmos G, DeGregorio-Rocasolano N, Paz Regalado M, et al. Protection by imidazol (ine) drugs and agmatine of glutamateinduced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor. Br J Pharmacol. 1999;127:1317-1326. (Pubitemid 29358932)
16. Galea E, Regunathan S, Eliopoulos V, et al. Inhibition of mammalian nitric oxide synthase by agmatine, an endogenous poyamine formed by decarboxylation of arginine. Biochem J. 1996; 316:247-249.
17. Auguet M, Viossat I, Marin JG, et al. Selective inhibition of inducible nitric oxide synthase by agmatine. Jpn J Pharmacol. 1995;69:285-287.
18. Kim JH, Lee YW, Park KA, et al. Agmatine attenuates brain edema through reducing the expression of aquaporin-1 after cerebral ischemia. J Cereb Blood Flow Metab. 2010;30:943-949.
19. Feng Y, Piletz JE, Leblanc MH. Agmatine suppresses nitric oxide production and attenunates hypoxic-ischemic brain injury in neonatal rats. Pediatr Res. 2002;52:606-611.
20. Gilad GM, Salame K, Rabey JM, et al. Agmatine treatment is neuroprotective in rodent brain injury models. Life Sci. 1996; 58:41-46.
21. Hunter AJ, Hatcher J, Virley D, et al. Functional assessments in mice and rats after focal stroke. Neuropharmacology. 2000;39: 806-816. (Pubitemid 30103684)
22. Garcia JH, Wagner S, Liu KF, et al. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke. 1995;26:627-635.
23. Rizk NN, Rafols JA, Dunbar JC. Cerebral ischemia-induced apoptosis and necrosis in normal and diabetic rats: effects of insulin and C-peptide. Brain Res. 2006;1096:204-212. (Pubitemid 43928921)
24. Britton M, Rafols J, Alousi S, et al. The effect of middle cerebral artery occlusion on central nervous system apoptotic events in normal and diabetic rats. Int J Exp Diabesity Res. 2003;4:13-20. (Pubitemid 37038669)
25. Li ZG, Britton M, Sima AA, et al. Diabetes enhances apoptosis induced by cerebral ischemia. Life Sci. 2004;76:249-262. (Pubitemid 39452909)
26. Rizk NN, Rafols JA, Dunbar JC. Cerebral ischemia induced apoptosis and necrosis in normal and diabetic rats. Brain Res. 2005;1053:1-9. (Pubitemid 41116784)
27. Hong S, Lee JE, Kim CY, et al. Agmatine protects retinal ganglion cells from hypoxia-induced apoptosis in transformed rat retinal ganglion cell line. BMC Neurosci. 2007;8:81.
28. Hong S, Kim CY, Lee JE, et al. Agmatine protects cultured retinal ganglion cells from tumor necrosis factor-alpha-induced apoptosis. Life Sci. 2009;84:28-32.
29. Zarifkar A, Choopani S, Ghasemi R, et al. Agmatine prevents LPS induced spatial memory impairment and hippocampal apoptosis. Eur J Pharmacol. 2010;634:84-88.
30. Iadecola C, Zhang F, Xu S, et al. Inducible nitric oxide synthase gene expression in brain following cerebral ischemia. J Cereb Blood Flow Metab. 1995;15:378-384.
31. Iadecola C, Zhang F, Casey R, et al. Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia. Stroke. 1996;27:1373-1380. (Pubitemid 26286171)
32. Zhu DY, Deng Q, Yao HH, et al. Inducible nitric oxide synthase expression in the ischemic core and penumbra after transient focal cerebral ischemia in mice. Life Sci. 2002;71:1985-1996.
33. González-Correa JA, Arrebola MM, Cansino AL, et al. Effects of hypoxia reoxygenation in brain slices from rats with type 1-like diabetes mellitus. Diabetes Metab Res Rev. 2006;22:390-400. (Pubitemid 44446435)
34. Celik S, Erdogan S. Caffeic acid phenethyl ester (CAPE) protects brain against oxidative stress and inflammation induced by diabetes in rats. Mol Cell Biochem. 2008;312:39-46.
35. Rimoldi JM, Chimote SS. Inhibition on inducible nitric oxide synthase. Curr Opin Drug Discov Devel. 1998;1:183-191.
36. Uehara T, Kikuchi Y, Nomura Y. Caspase activation accompanying cytochrome c release from mitochondria is possibly involved in nitric oxide-induced neuronal apoptosis in SH-SY5Y cells. J Neurochem. 1999;72:196-205. (Pubitemid 29013893)
37. Piletz JE, Chikkala DN, Ernsberger P. Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazolind and alpha-2 adrenergic receptors. J Pharmacol Exp Ther. 1995;272:581-587.
38. Reynolds J. Arcaine uncovers dual interactions of polyamines with the N-methyl-D-aspartate receptor. J Pharmacol Exp Ther. 1990; 255:1001-1009.
39. Demady DR, Jianmongkol S, Vuletich JL, et al. Agmatine enhances the NADPH oxidase activity of neuronal NO synthase and leads to oxidative inactivation of the enzyme. Mol Pharmacol. 2001;59:24-29. (Pubitemid 32043081)
40. Hwang SL, Liu IM, Tzeng TF, et al. Activation of imidazoline receptors in adrenal gland to lower plasma glucose in streptozotocin- induced diabetic rats. Diabetologica. 2005;48:767-775.
41. Nagareddy PR, Xia Z, NcNeil JH, et al. Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes. Am J Physiol Heart Circ Physiol. 2005;289:H2144-H2152. (Pubitemid 41507367)